This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

Kit Components of INVEGA TRINZA

Last Updated: 02/10/2025

Abbreviations: IM, intramuscular.
aINVEGA TRINZA [(paliperidone palmitate) Extended-Release Injectable Suspension] [Prescribing Information].1

PRODUCT LABELING

Please refer to the following sections of the Full Prescribing Information1 that are relevant to your inquiry: DOSAGE AND ADMINISTRATION and HOW SUPPLIED/STORAGE AND HANDLING.

DOSAGE STRENGTHS AND INJECTION VOLUMES

INVEGA TRINZA is supplied in prefilled syringes with a concentration of 312 mg/mL of paliperidone palmitate.2 The volume has been rounded on the carton due to space considerations. Each syringe contains the correct volume for injection based on the dose of paliperidone palmitate (see Table: Dosage Strengths and Injection Volumes per Dose of INVEGA TRINZA).


Dosage Strengths and Injection Volumes per Dose of INVEGA TRINZA1
Strength
Volume
NDC #
273 mg paliperidone palmitate
0.88 mL
50458-606-01
410 mg paliperidone palmitate
1.32 mL
50458-607-01
546 mg paliperidone palmitate
1.75 mL
50458-608-01
819 mg paliperidone palmitate
2.63 mL
50458-609-01

References

1 INVEGA TRINZA (paliperidone palmitate) extended-release injectable suspension [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INVEGA+TRINZA-pi.pdf
2 Data on File. Janssen Research & Development, LLC. INVEGA TRINZA - Clinical Overview; 2014.